Cargando…
Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis
Systemic sclerosis (SSc) is an immune-mediated fibrotic disease affecting skin, lung and gut which are all sites with an established microbiome. Altered microbial flora may occur and contribute to the initiation, progression or severity of disease. However, dysbiosis could also be secondary to the d...
Autores principales: | Denton, Christopher P., Murray, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437947/ https://www.ncbi.nlm.nih.gov/pubmed/30917857 http://dx.doi.org/10.1186/s13075-019-1872-4 |
Ejemplares similares
-
State-of-the-art evidence in the treatment of systemic sclerosis
por: Pope, Janet E., et al.
Publicado: (2023) -
Therapeutic targets in systemic sclerosis
por: Denton, Christopher P
Publicado: (2007) -
Oral Dysbiosis and Systemic Diseases: A Two-Way Relationship?
por: Pisano, Massimo
Publicado: (2023) -
Tracking Dysbiosis Where It Matters
por: Kaestner, Klaus H.
Publicado: (2019) -
Mycobiota dysbiosis and gastric tumorigenesis
por: Papon, Nicolas, et al.
Publicado: (2021)